Search research articles
Contact Us
Filters
Showing results (631-640 of 688) with videos related to
Page
of 69
Sort By:
JAMA Network Open
|
November 6, 2023
Guideline-Based Follow-Up Outcomes in Patients With Gastrointestinal Stromal Tumor With Low Risk of Recurrence: A Report From the Italian Sarcoma Group
Lorenzo D'Ambrosio, Elena Fumagalli, Tommaso Martino De Pas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 27, 2022
Novel Lymphocyte-Independent Antitumor Activity by PD-1 Blocking Antibody against PD-1+ Chemoresistant Lung Cancer Cells
Ramona Rotolo, Valeria Leuci, Chiara Donini, et al.
The Lancet. Oncology
|
May 14, 2017
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial
Alessandro Gronchi, Stefano Ferrari, Vittorio Quagliuolo, et al.
Molecular Cancer Research : MCR
|
January 29, 2017
Genome-Wide Analysis Identifies MEN1 and MAX Mutations and a Neuroendocrine-Like Molecular Heterogeneity in Quadruple WT GIST
Maria A Pantaleo, Milena Urbini, Valentina Indio, et al.
Cancer
|
August 16, 2020
Patterns of recurrence and survival probability after second recurrence of retroperitoneal sarcoma: A study from TARPSWG
Winan J van Houdt, Marco Fiore, Francesco Barretta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 17, 2024
Neoadjuvant Chemotherapy in High-Grade Myxoid Liposarcoma: Results of the Expanded Cohort of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish Sarcoma Groups (PSG)
Alessandro Gronchi, Emanuela Palmerini, Vittorio Quagliuolo, et al.
ESMO Open
|
March 8, 2025
Redefining radiologic responses in high-risk soft-tissue sarcomas treated with neoadjuvant chemotherapy: final results of ISG-STS 1001, a randomized clinical trial
A Vanzulli, R Vigorito, C Buonomenna, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 19, 2020
Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups
Alessandro Gronchi, Emanuela Palmerini, Vittorio Quagliuolo, et al.
Molecular Cancer
|
August 9, 2023
REGISTRI: Regorafenib in first-line of KIT/PDGFRA wild type metastatic GIST: a collaborative Spanish (GEIS), Italian (ISG) and French Sarcoma Group (FSG) phase II trial
Javier Martin-Broto, Claudia Valverde, Nadia Hindi, et al.
Journal of Surgical Oncology
|
December 28, 2020
Primary mesenteric sarcomas: Collaborative experience from the Trans-Atlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG)
Hannah L Tattersall, James Hodson, Kenneth Cardona, et al.
Page
of 69
Search research articles
Search
Showing results (631-640 of 688) with videos related to
Sort By:
Page
of 69
JAMA Network Open
|
November 6, 2023
Guideline-Based Follow-Up Outcomes in Patients With Gastrointestinal Stromal Tumor With Low Risk of Recurrence: A Report From the Italian Sarcoma Group
Lorenzo D'Ambrosio, Elena Fumagalli, Tommaso Martino De Pas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 27, 2022
Novel Lymphocyte-Independent Antitumor Activity by PD-1 Blocking Antibody against PD-1+ Chemoresistant Lung Cancer Cells
Ramona Rotolo, Valeria Leuci, Chiara Donini, et al.
The Lancet. Oncology
|
May 14, 2017
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial
Alessandro Gronchi, Stefano Ferrari, Vittorio Quagliuolo, et al.
Molecular Cancer Research : MCR
|
January 29, 2017
Genome-Wide Analysis Identifies MEN1 and MAX Mutations and a Neuroendocrine-Like Molecular Heterogeneity in Quadruple WT GIST
Maria A Pantaleo, Milena Urbini, Valentina Indio, et al.
Cancer
|
August 16, 2020
Patterns of recurrence and survival probability after second recurrence of retroperitoneal sarcoma: A study from TARPSWG
Winan J van Houdt, Marco Fiore, Francesco Barretta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 17, 2024
Neoadjuvant Chemotherapy in High-Grade Myxoid Liposarcoma: Results of the Expanded Cohort of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish Sarcoma Groups (PSG)
Alessandro Gronchi, Emanuela Palmerini, Vittorio Quagliuolo, et al.
ESMO Open
|
March 8, 2025
Redefining radiologic responses in high-risk soft-tissue sarcomas treated with neoadjuvant chemotherapy: final results of ISG-STS 1001, a randomized clinical trial
A Vanzulli, R Vigorito, C Buonomenna, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 19, 2020
Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups
Alessandro Gronchi, Emanuela Palmerini, Vittorio Quagliuolo, et al.
Molecular Cancer
|
August 9, 2023
REGISTRI: Regorafenib in first-line of KIT/PDGFRA wild type metastatic GIST: a collaborative Spanish (GEIS), Italian (ISG) and French Sarcoma Group (FSG) phase II trial
Javier Martin-Broto, Claudia Valverde, Nadia Hindi, et al.
Journal of Surgical Oncology
|
December 28, 2020
Primary mesenteric sarcomas: Collaborative experience from the Trans-Atlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG)
Hannah L Tattersall, James Hodson, Kenneth Cardona, et al.
Page
of 69